Expanded Access to Everolimus, for an Individual Patient With Uterine Sarcoma (CTMS#18-0020)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Clinical Trials Related to Everolimus
Related studies linked through entity extraction aliases.
Expanded Access to Everolimus, for an Individual Patient With GIST (Gastrointestinal Stromal Tumors)(CTMS#18-0019)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation
- Status
- COMPLETED
- Phase
- PHASE4
Everolimus and Tacrolimus Combination for Regression of Left Ventricular Hypertrophy in Renal Transplants
- Status
- COMPLETED
- Phase
- PHASE4
Alterations in Cognitive Function and Cerebral Blood Flow After Conversion From Calcineurin Inhibitors (CNIs) to Everolimus
- Status
- COMPLETED
- Phase
- N/A
Ribociclib and Everolimus in Treating Children With Recurrent or Refractory Malignant Brain Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Tacrolimus/Everolimus vs. Tacrolimus/MMF in Pediatric Heart Transplant Recipients Using the MATE Score
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations
- Status
- TERMINATED
- Phase
- PHASE2
Everolimus in Combination With Nelarabine, Cyclophosphamide and Etoposide in Lymphoblastic Leukemia/Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Lenvatinib and Everolimus in Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Everolimus Plus Exemestane in Chinese Postmenopausal Women With Estrogen Receptor Positive, Locally Advanced, Recurrent, or Metastatic Breast Cancer After Recurrence or Progression on Non-steroidal Aromatase Inhibitor
- Status
- COMPLETED
- Phase
- PHASE2
Treatment Plan for an Individual Patient With Recurrent Uterine Papillary Serous Carcinoma (UPSC) With PIK3CA Gene Mutation
- Status
- COMPLETED
- Phase
- PHASE2/PHASE3
Phase 1/2 Study of Amcenestrant (SAR439859) Single Agent and in Combination With Other Anti-cancer Therapies in Postmenopausal Women With Estrogen Receptor Positive Advanced Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric Solid Tumors, Including Central Nervous System Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Efficacy and Safety of Precision Therapy in Refractory Tumor
- Status
- UNKNOWN
- Phase
- PHASE2
Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia.
- Status
- COMPLETED
- Phase
- PHASE4
Study in Post-menopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Trial to Assess Safety and Efficacy of Lenvatinib (18 mg vs. 14 mg) in Combination With Everolimus in Participants With Renal Cell Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
CB-839 With Everolimus vs. Placebo With Everolimus in Participants With Renal Cell Carcinoma (RCC)
- Status
- COMPLETED
- Phase
- PHASE2